TTR

22 drugs in development·15 companies·0 clinical trials

Drug Pipeline by Phase

Approved(8)

Drug	Company
Amvuttra	Royalty Pharma plc (RPRX)
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
attruby	BridgeBio Pharma, Inc. (BBIO)
ONPATTRO	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
paroxetine	Mylan II B.V. (MYL)
paroxetine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
supplemental new drug	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tegsedi	PTC THERAPEUTICS, INC. (PTCT)

Phase 3(8)

Drug	Company
akcea-ttr-lrx	AKCEA THERAPEUTICS, INC. (AKCA)
coramitug	PROTHENA CORP PUBLIC LTD CO (PRTA)
eplontersen	IONIS PHARMACEUTICALS INC (IONS)
eplontersen	ASTRAZENECA PLC (AZN)
nnc6019-0001	Novo Nordisk A/S (NVO)
NNC6019-0001	PROTHENA CORP PUBLIC LTD CO (PRTA)
Patisiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Vutrisiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 2(2)

Drug	Company
alxn2220	ASTRAZENECA PLC (AZN)
NNC6019	PROTHENA CORP PUBLIC LTD CO (PRTA)

Phase 1(1)

Drug	Company
NTLA-2001	Intellia Therapeutics, Inc. (NTLA)

Preclinical(2)

Drug	Company
ag10	Eidos Therapeutics, Inc. (EIDX)
ag10	ALEXION PHARMACEUTICALS, INC. (ALXN)

Phase 4(1)

Drug	Company
sertraline	GH Research PLC (GHRS)

Compare drugs

Amvuttra vs attruby Amvuttra vs ONPATTRO Amvuttra vs paroxetine

Deep-dive into TTR

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis